A new open-access lab for early-stage medtech and biotech companies has launched in Manchester.

BiOspace, based at Manchester Science Park, will provide businesses and entrepreneurial individual scientists with unrestricted, pay-as-you-go access to state-of-the-art facilities and equipment.

Customers will also be able to access specialised training from experienced PhD scientists on drug discovery, protein production, diagnostics development and prototyping medical devices.

The biotech lab is a joint venture between science and technology park operator Manchester Science Partnerships (MSP) and award-winning biotech firm Protein Technologies.

Equipment and bench space at the lab are available on a daily basis, but can be booked for up to 12 months.

“By providing pay-as-you-go access to multi-million pound equipment, and the expertise to accompany it, we’re removing barriers to bright, individual scientists developing tomorrow’s breakthrough treatments,” BiOspace founder and chair of Protein Technologies Dr Farid Khan said.


“Manchester has Europe’s largest student population, and ready access to grant funding through the Greater Manchester and Cheshire Life Sciences Fund and GM Academic Health Science Network, and the Business Growth Hub. The city region has a healthy mix of novel ideas, and the financial support to see them realised.

“BiOspace offers the ideal environment for interdisciplinary collaboration, with experts in biology, 3D printing, electronics and software development co-working in one facility.”

Thomas Renn, MSP managing director, added: “We’re passionate about supporting innovative businesses at every stage of their life cycle. The launch of this flexible new facility for very early-stage businesses is an important step.

"With reduced overheads, and the business support network afforded by the MSP community, entrepreneurs have access to an environment conducive to measured risk-taking and meaningful collaboration – both essential elements of a thriving knowledge economy.”